Matchbox plans to sell Ted’s Bulletin locations
Regional restaurant chain Matchbox is planning to sell its five Ted’s Bulletin locations, including the Gaithersburg restaurant, as the company seeks to streamline its operations, according to The Washington Business Journal.
Steve Salis, the co-founder of &pizza, is the reported buyer. The move comes as Matchbox is reorganizing after taking on significant debt to expand in 2016 when it opened new regional locations, as well as restaurants in Texas and Florida, according to the report.
Ted’s Bulletin is a diner-style restaurant known for its decadent Pop-Tarts and alcoholic milkshakes.
Discovery named one of best companies for working mothers for 18th straight year
Discovery Communication was once again named to Working Mother magazine’s list of the 100 best companies for working mothers. It was the 18th time the Silver Spring-based media company made the list. Discovery was recognized for its child care and paid parental leave programs.
The company’s programs allow new moms to take up to 20 fully paid weeks off and also gives domestic partners and fathers of a new child up to 12 weeks off, according to the magazine.
“Supporting our employees is a major part of our philosophy, and our DNA, at Discovery,” Adria Alpert Romm, the human resources chief for Discovery, said in a statement about being named to the list. She added that the policies help attract talented workers.
Bethesda-based Marriott also was included on the list. The magazine noted that 41 percent of the hotel company’s executives in 2016 were women.
Gaithersburg biotech firm gets $63 million contract to develop cyanide exposure treatment
Gaithersburg-based Emergent BioSolutions announced this month it has secured a contract valued at approximately $63 million to develop an antidote spray to treat cyanide poisoning. The single-use nasal spray will be designed to be used by first responders and other medical workers after a cyanide incident.
Cyanide is a highly toxic compound that can cause death within minutes if even a small amount is inhaled.
The Biomedical Advanced Research and Development Authority, a part of the federal Health and Human Services office, awarded the five-year contract.
“Emergent has a successful history of developing medical countermeasures that address the U.S. government’s top priority public health threats,” Sean Kirk, a vice president at Emergent, said in a statement.